Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Oral Primaquine and Pharmacokinetics of Carboxyprimaquine
NCT05938608Phase 1Withdrawn
- Sponsor
- University of Oxford
- Start
- Mar 2024
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of primaquine in malaria, sponsored by University of Oxford. Primary endpoints: Area under the concentration-time curve from time zero to infinity, Area under the concentration-time curve from time zero to the last measurable concentration and 4 more. Planned start Mar 2024; status: withdrawn.
02
Drugs
primaquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT05938608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05938608.